---
title: "Peptides for Weight Loss: GLP-1 Agonists and Supportive Options"
url: https://stargirlpodcast.com/what-peptides-help-with-weight-loss/
description: "GLP-1 agonists such as semaglutide and tirzepatide produce the strongest weight loss results among peptides. Other compounds support fat metabolism and muscle."
published: 2026-09-14
updated: 2026-09-14
---

# Peptides for Weight Loss: GLP-1 Agonists and Supportive Options

Published 2026-09-14

GLP-1 receptor agonists such as semaglutide and tirzepatide are the peptides with the strongest clinical evidence for helping with weight loss.

These compounds mimic gut hormones that slow digestion, reduce appetite, and improve blood sugar control. When combined with diet and activity changes, they produce average body weight reductions of about 15 percent with semaglutide and up to 22 percent with tirzepatide. Both agents are FDA-approved for chronic weight management.

## GLP-1 Receptor Agonists

Semaglutide acts on a single GLP-1 receptor and is sold under the brand names Wegovy and Ozempic. Tirzepatide targets both GLP-1 and GIP receptors, which appears to enhance fat metabolism and insulin sensitivity; it is sold as Mounjaro and Zepbound. A newer triple agonist called retatrutide, still in development, targets GLP-1, GIP, and glucagon receptors and shows early promise for further metabolic improvements.

## Growth Hormone Releasing Peptides

Compounds such as CJC-1295, ipamorelin, and sermorelin stimulate the pituitary gland to release growth hormone. This action supports fat breakdown and helps maintain lean muscle during calorie restriction, but these peptides do not directly cause scale weight loss on their own. They are most useful when paired with resistance training and adequate protein intake to preserve body composition. For related context, see our guide to [How to Eat Granola for Weight Loss: Portions, Pairings, and Picks](https://stargirlpodcast.com/how-to-eat-granola-for-weight-loss/).

## Fat-Targeting Peptides

AOD-9604 is a fragment of human growth hormone engineered to promote fat breakdown without affecting blood sugar levels. Tesamorelin is FDA-approved specifically for reducing visceral fat in people with HIV-associated lipodystrophy and is sometimes used off-label for abdominal fat reduction. Both require medical oversight when employed for general weight management.

## Additional Supporting Peptides

Other peptides influence recovery or metabolic flexibility rather than drive direct weight reduction. BPC-157 may improve gut health and insulin sensitivity. MOTS-c affects mitochondrial function and fat oxidation. These agents can complement a broader plan that includes diet and exercise but are not primary weight loss tools.

## Common Combinations and Practical Use

Clinicians sometimes combine a GLP-1 agonist with AOD-9604 to pair appetite control with targeted fat metabolism. CJC-1295 paired with ipamorelin is another frequent regimen that aims to boost growth hormone while minimizing side effects. All peptides are typically given by subcutaneous injection under physician supervision. Side effects of GLP-1 agonists can include nausea and gastrointestinal discomfort, while growth hormone releasing peptides may cause fluid retention or headaches.

## Important Limitations and Monitoring

Results vary according to starting weight, adherence to diet, and exercise habits. Most peptides used for weight loss beyond the approved GLP-1 agonists are employed off-label, so regular lab monitoring and body composition tracking are essential. Individuals should consult a qualified clinician before starting any peptide regimen to assess suitability and manage potential risks.

## Sources

- Research and prospect of peptides for use in obesity ... - PMC
- Peptides for Weight Loss Explained: GLP-1, CJC-1295, ...
- Best Peptides for Weight Loss: What Actually Works
- Peptide Therapy for Fat Loss: Does It Really Work?